EntryPoint Capital’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,336
Closed -$243K 794
2026
Q1
$243K Buy
+7,336
New +$239K 0.07% 560
2025
Q2
Sell
-21,683
Closed -$401K 620
2025
Q1
$401K Buy
+21,683
New +$391K 0.18% 187

Other funds holding AXGN

EntryPoint Capital's AXGN Position: Q2 2026 in Review

EntryPoint Capital sold out of Axogen (AXGN) in Q2 2026, closing a stake of 7,336 shares — an estimated $243K sold.

EntryPoint Capital first reported a position in AXGN in Q1 2025 and held it in 2 quarters. The position peaked at $401K in Q1 2025. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • EntryPoint Capital reported no remaining Axogen position as of Q2 2026 after selling out during the quarter.
  • EntryPoint Capital sold 7,336 Axogen shares in Q2 2026, an estimated $243K.
  • EntryPoint Capital first reported a position in Axogen in Q1 2025 and held it in 2 quarters.
  • EntryPoint Capital's Axogen position peaked at $401K in Q1 2025.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.